These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 28262237)

  • 1. Outcome after discontinuing anticoagulant therapy in women with venous thromboembolism during hormonal use.
    Blanco-Molina Á; Trujillo-Santos J; Pesavento R; Rosa V; Falgá C; Tolosa C; Mazzolai L; Sampériz Á; Duce R; Monreal M;
    Thromb Res; 2017 Mar; 151 Suppl 1():S6-S10. PubMed ID: 28262237
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gender-related differences in the outcome of patients with venous thromboembolism and thrombophilia.
    Tzoran I; Papadakis E; Brenner B; Valle R; López-Jiménez L; García-Bragado F; Riera-Mestre A; Villalobos A; Quintavalla R; Monreal M;
    Thromb Res; 2017 Mar; 151 Suppl 1():S11-S15. PubMed ID: 28262227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical outcomes after discontinuing anticoagulant therapy in patients with first unprovoked venous thromboembolism.
    Gabara C; Aibar J; Nishimoto Y; Yamashita Y; Prandoni P; Barnes GD; Bikdeli B; Jiménez D; Demelo-Rodríguez P; Peris ML; Nguyen ST; Monreal M;
    J Thromb Haemost; 2024 Aug; 22(8):2234-2246. PubMed ID: 38762019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Uterine bleeding during anticoagulation in women with venous thromboembolism.
    Moustafa F; Fernández S; Fernández-Capitán C; Nieto JA; Pedrajas JM; Visoná A; Valero B; Marchena PJ; Braester A; Monreal M;
    Thromb Res; 2017 Mar; 151 Suppl 1():S1-S5. PubMed ID: 28262225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. D-dimer testing to select patients with a first unprovoked venous thromboembolism who can stop anticoagulant therapy: a cohort study.
    Kearon C; Spencer FA; O'Keeffe D; Parpia S; Schulman S; Baglin T; Stevens SM; Kaatz S; Bauer KA; Douketis JD; Lentz SR; Kessler CM; Moll S; Connors JM; Ginsberg JS; Spadafora L; Julian JA;
    Ann Intern Med; 2015 Jan; 162(1):27-34. PubMed ID: 25560712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of recurrent venous thromboembolism in patients with HIV infection: A nationwide cohort study.
    Rokx C; Borjas Howard JF; Smit C; Wit FW; Pieterman ED; Reiss P; Cannegieter SC; Lijfering WM; Meijer K; Bierman W; Tichelaar V; Rijnders BJA;
    PLoS Med; 2020 May; 17(5):e1003101. PubMed ID: 32407386
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Venous thromboembolism in patients with glioblastoma multiforme: Findings of the RIETE registry.
    Portillo J; de la Rocha IV; Font L; Braester A; Madridano O; Peromingo JA; Apollonio A; Pagán B; Bascuñana J; Monreal M;
    Thromb Res; 2015 Dec; 136(6):1199-203. PubMed ID: 26548619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. D-dimer levels and risk of recurrence following provoked venous thromboembolism: findings from the RIETE registry.
    Avnery O; Martin M; Bura-Riviere A; Barillari G; Mazzolai L; Mahé I; Marchena PJ; Verhamme P; Monreal M; Ellis MH;
    J Intern Med; 2020 Jan; 287(1):32-41. PubMed ID: 31394000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between anticoagulant treatment duration and risk of venous thromboembolism recurrence and bleeding in clinical practice.
    Kaatz S; Fu AC; AbuDagga A; LaMori J; Bookhart BK; Damaraju CV; Tan H; Schein J; Nutescu E
    Thromb Res; 2014 Oct; 134(4):807-13. PubMed ID: 25127013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of recurrent venous thromboembolism after a first oestrogen-associated episode. Data from the REVERSE cohort study.
    Le Gal G; Kovacs MJ; Carrier M; Do K; Kahn SR; Wells PS; Anderson DA; Chagnon I; Solymoss S; Crowther M; Righini M; Lacut K; White RH; Vickars L; Rodger M
    Thromb Haemost; 2010 Sep; 104(3):498-503. PubMed ID: 20539910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Statin and all-cause mortality in patients receiving anticoagulant therapy for venous thromboembolism. Data from the RIETE registry.
    Siniscalchi C; Quintavalla R; Rocci A; Riera-Mestre A; Trujillo-Santos J; Suriñach JM; Jara-Palomares L; Bikdeli B; Moustafa F; Monreal M;
    Eur J Intern Med; 2019 Oct; 68():30-35. PubMed ID: 31427187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. B blood group: A strong risk factor for venous thromboembolism recurrence.
    Baudouy D; Moceri P; Chiche O; Bouvier P; Schouver ED; Cerboni P; Gibelin P; Ferrari E
    Thromb Res; 2015 Jul; 136(1):107-11. PubMed ID: 25981188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Venous thromboembolism in young adults: Findings from the RIETE registry.
    Lacruz B; Tiberio G; Latorre A; Villalba JC; Bikdeli B; Hirmerova J; Lorenzo A; Mellado M; Cañas I; Monreal M;
    Eur J Intern Med; 2019 May; 63():27-33. PubMed ID: 30871951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics, treatment patterns and outcomes of patients presenting with venous thromboembolic events after knee arthroscopy in the RIETE Registry.
    Weinberg I; Giri J; Kolluri R; Arcelus JI; Falgá C; Soler S; Braester A; Bascuñana J; Gutiérrez-Guisado J; Monreal M;
    J Thromb Thrombolysis; 2018 Nov; 46(4):551-558. PubMed ID: 30196344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anticoagulant therapy for venous thromboembolism in patients with inflammatory bowel disease.
    Lobo JL; Garcia-Fuertes JA; Trujillo-Santos J; Merah A; Blanco-Molina MÁ; Casado I; Hirmerova J; De Miguel J; Salgado E; Monreal M;
    Eur J Gastroenterol Hepatol; 2018 May; 30(5):526-530. PubMed ID: 29462026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of recurrent venous thromboembolism among young women after a first event while exposed to combined oral contraception versus not exposed to: a cohort study.
    Le Moigne E; Delluc A; Tromeur C; Nowak E; Mottier D; Lacut K; Le Gal G
    Thromb Res; 2013 Jul; 132(1):51-5. PubMed ID: 23786893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patient-level meta-analysis: effect of measurement timing, threshold, and patient age on ability of D-dimer testing to assess recurrence risk after unprovoked venous thromboembolism.
    Douketis J; Tosetto A; Marcucci M; Baglin T; Cushman M; Eichinger S; Palareti G; Poli D; Tait RC; Iorio A
    Ann Intern Med; 2010 Oct; 153(8):523-31. PubMed ID: 20956709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence of major adverse cardiovascular events among patients with provoked and unprovoked venous thromboembolism: Findings from the Registro Informatizado de Enfermedad Tromboembólica Registry.
    Golemi I; Cote L; Iftikhar O; Brenner B; Tafur A; Bikdeli B; Fernández-Capitán C; Pedrajas JM; Otero R; Quintavalla R; Monreal M;
    J Vasc Surg Venous Lymphat Disord; 2020 May; 8(3):353-359.e1. PubMed ID: 31784355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gender differences in patients with venous thromboembolism and five common sites of cancer.
    Martín-Martos F; Trujillo-Santos J; Del Toro J; Bura-Riviere A; Lorenzo A; Barillari G; Soler S; Mahè I; Sahuquillo JC; Monreal M;
    Thromb Res; 2017 Mar; 151 Suppl 1():S16-S20. PubMed ID: 28262228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Optimal duration of anticoagulation of venous thromboembolism].
    Savina EN; Couturaud F
    J Mal Vasc; 2011 Dec; 36 Suppl 1():S28-32. PubMed ID: 22177766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.